Inovio Pharmaceuticals, Inc. (INO) vs Outset Medical, Inc. (OM)
A side-by-side comparison of Inovio Pharmaceuticals, Inc. and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INO
Inovio Pharmaceuticals, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OM
Outset Medical, Inc.
$4.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INO vs OM
growth of $100 · dividends reinvested · last 6yINO -99.0% (-53.7%/yr)OM -99.5% (-59.4%/yr)INO compounded faster over this window
INO OM
INO vs OM: by the numbers
- •INO is the larger company ($78M vs $77M market cap).
- •Both run net losses; OM's is the smaller (-63.06% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | INO | OM |
|---|---|---|
| P/S ratio | N/A | 0.65 |
| P/B ratio | 17.86 | 0.80 |
Profitability
| Metric | INO | OM |
|---|---|---|
| Gross margin | 100.00% | 41.76% |
| Operating margin | -132871.32% | -56.06% |
| Net margin | -130000.00% | -63.06% |
| ROE | -1542.57% | -77.12% |
| ROIC | -836.58% | -33.27% |
Growth (annualized)
| Metric | INO | OM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.28% |
| Total return CAGR (5Y) | -57.05% | -64.47% |
Frequently asked
- How have INO and OM total returns compared?
- Over the past 5 years, INO delivered -57.05% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.